A case report from the AGMT mCRC Registry describes successful rechallenge with encorafenib and cetuximab combined with nivolumab in a patient with BRAF V600E mutated, mismatch-repair-proficient metastatic colorectal cancer. (Clinical Colorectal Cancer)
Encorafenib, cetuximab, and nivolumab rechallenge succeeds in BRAF V600E mCRC case
The CRC Digest